BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 22, 2009
View Archived Issues
Novel P2X7 receptor antagonists jointly discovered by AMRI and Schering-Plough researchers
Read More
Recent Roche patent reports new antipsychotic tachykinin NK3 receptor antagonists
Read More
Kyorin scientists describe new antibacterial mutilin derivatives
Read More
Novel mGluR5 receptor modulators with antipsychotic properties developed at GSK
Read More
Four Novartis medicines approved in a single day in Japan
Read More
Celldex licenses cholera and ETEC vaccine programs to Vaccine Technologies
Read More
Alexza initiates phase IIb clinical trial of Staccato loxapine in migraine
Read More
S*BIO grants worldwide exclusive license to Tragara to develop and commercialize SB-1317
Read More
Ablynx transfers in-house bone disorder R&D program with Procter & Gamble
Read More
3SBio files for approval in China for TPIAO label extension in ITP
Read More
Clinuvel reports positive phase III interim results for afamelanotide in EPP
Read More
European marketing authorization application for Flutiform delayed
Read More
Opexa provides update on pipeline developments
Read More
Xoma provides guidance update for 2008
Read More
Parkinson's disease drug Trerief obtains marketing approval in Japan
Read More
Recalbon/Bonoteo tablets approved in Japan for osteoporosis treatment
Read More
Bristol-Myers Squibb receives approval in Japan for Sprycel
Read More
Remitch approved in Japan for improvement of pruritus in hemodialysis patients
Read More
Merck & Co. divulge new gamma-secretase modulators for Alzheimer's disease
Read More
AVI reports positive results from phase I trial of AVI-4658 for DMD
Read More
Ecard approved in Japan for hypertension
Read More
RegeneRx presents update on clinical development of RGN-259 for nonhealing corneal ulcers
Read More
Aradigm reports positive results from phase II study of ILCH in bronchiectasis
Read More
Improved cyclin-dependent kinase inhibitor developed at Greenpharma
Read More
Vitamin effect on homocystine levels does not affect Abeta levels in stroke patients
Read More